News
Italian Biotech company Kedrion Biopharma plans plasma-based treatment launch for COVID-19 by late summer of 2020
Kedrion plans to use plasma from about 100 patients who have recovered from COVID-19 in order to develop a dosage that can be injected intravenous or intramuscularly.
CSIR-CFTRI to provide testing equipment for COVID-19 detection
CSIR-CFTRI is providing two PCR machines and one RNA extraction unit along with necessary chemicals to the district administration for coping with the large number of samples to be tested in the district
IIT-M researchers develop algorithms to detect disease-causing dysfunctional proteins &genes in biological networks
They hope to develop detailed maps of tissue- & disease-specific networks in future that can help in better understanding of the connections among genes, proteins and diseases
